/EINPresswire.com/ -- REDWOOD CITY, CA--(Marketwired - March 06, 2018) - Pliant Therapeutics, Inc., a company focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases, announced today that President and Chief Executive Officer, Bernard Coulie, M.D. Ph.D., will present at the 38^th Annual Cowen Healthcare Conference being held in Boston, MA from March 12^th - 14^th, 2018.

Details of the presentation are as follows:

38^th Annual Cowen Healthcare Conference
Date: Tuesday March 13^th, 2018
Location: Boston, MA
Presentation Time: 2:30 PM ET

About Pliant Therapeutics

Pliant Therapeutics is a pre-clinical stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. By leveraging its powerful product engine, Pliant's mission is to prevent or even reverse fibrosis, restoring organ function. The company's pipeline includes a late preclinical stage proprietary dual selective inhibitor for a_Vb₆ and a_Vb₁ integrins. Other, earlier stage programs include integrin and TGF-b signaling targets for multiple fibrotic diseases. For more information, please visit www.pliantrx.com.